Rheumatoid Arthritis

Latest News

Medical concept of FDA approved. Food and drugs administration quality control. | Image Credit: wladimir1804 - stock.adobe.com
FDA Approves Tocilizumab-aazg as Biosimilar to Actemra for Multiple Indications

March 7th 2024

Tocilizumab-aazg (Tyenne; Fresenius Kabi) is the first approved biosimilar to tocilizumab (Actemra; Genentech) as both intravenous and subcutaneous.

Treatment by acupuncture | Image Credit: Max Tactic - stock.adobe.com
Acupuncture May Reduce Risk of Stroke Associated With Rheumatoid Arthritis

March 1st 2024

Making “Rheum” for Biosimilars: Overcoming Reluctance
Making “Rheum” for Biosimilars: Overcoming Reluctance

February 19th 2024

Close up of rheumatism / arthritis medical examination. | Image Credit: narstudio - stock.adobe.com
Biosimilar Adalimumab, Etanercept Have Equivalent Effectiveness to Reference Drugs Over 48 Months

February 9th 2024

Young woman having rheumatoid arthritis takes a rest sitting on the couch elected focus. | Image Credit: Valentina - stock.adobe.com
Celltrion Seeks Approval From FDA for CT-P47 as Biosimilar of Tocilizumab

February 6th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.